Today's story
Zydus Lifesciences plans Phase III Desidustat trial sickle cell ICMR
Zydus Lifesciences has received regulatory approval to initiate a 203-day Phase III trial of Desidustat for sickle cell disease in collaboration with ICMR, enrolling 164 patients to assess efficacy and safety of the oral tablet. The move follows successful Phase II results and US FDA Orphan Drug Designation, underscoring a public-private effort to address India's substantial SCD burden.
Health · 6 sources · Jul 23, 2026Read itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Indian Council of Medical Research
The Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest and largest medical research bodies in the world.
Everything about Indian Council of Medical Research →- Country
- India
- Headquarters
- New Delhi
- Inception
- 1948
- Website
- https://www.icmr.gov.in/